Tian S L, Zhao S W, Zhu A T, Fang Y, Li K Q
National Institutes of Pharmaceutical Research & Development, Beijing.
Yao Xue Xue Bao. 1993;28(11):870-5.
In order to search for new compounds with higher anti-cancer activities and lower toxicities, 19 amino acid derivatives of norcantharidin, of which 16 are unknown compounds, were designed and synthesized. Preliminary screening results revealed that 2-(syn-exo-7-oxabicyclo [2.2.1] heptane-2,3-dicarboxylic imido)-N-phenyl glutaramic acid exhibited a fairly apparent inhibitory activity against human-hepatoma cells in vitro (inhibitory rate 39.4% at 0.025 mumol/ml).
为了寻找具有更高抗癌活性和更低毒性的新化合物,设计并合成了19种去甲斑蝥素的氨基酸衍生物,其中16种为未知化合物。初步筛选结果显示,2-(顺式-外向-7-氧杂双环[2.2.1]庚烷-2,3-二甲酰亚胺基)-N-苯基谷氨酸在体外对人肝癌细胞表现出相当明显的抑制活性(在0.025 μmol/ml时抑制率为39.4%)。